📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: BioImagene

1.1 - Company Overview

BioImagene Logo

BioImagene

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of digital pathology solutions for clinical diagnostics and drug discovery, delivering integrated hardware and software systems to acquire, view, share, manage, archive, and analyze tissue images in pathology laboratories, including IHC algorithms such as HER2, ER/PR, and p53.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to BioImagene

Bicara Therapeutics Logo

Bicara Therapeutics

HQ: United States Website
  • Description: Provider of dual-action cancer therapies combining targeted treatments with tumor modulators. Offers BCA101, a dual-action bifunctional antibody that inhibits EGFR and disables TGF-β at the tumor site, in clinical trials across multiple cancer types; and BCA356, a bispecific antibody targeting CAIX conjugated to attenuated IL-12, with pre-clinical efficacy and potential for limited systemic toxicity.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Bicara Therapeutics company profile →
Algeta Logo

Algeta

HQ: Norway Website
  • Description: Provider of targeted oncology therapies based on an alpha-pharmaceutical platform, including radium-223 dichloride, which completed Phase III clinical trial to treat castration-resistant prostate cancer with bone metastases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Algeta company profile →
CellGate Logo

CellGate

HQ: United States Website
  • Description: Provider of anti-proliferative pharmaceutical products and cancer therapeutics, with applications in age-related macular degeneration, infectious diseases, inflammatory diseases, and vascular hyperplasia.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full CellGate company profile →
DYSIS Medical Logo

DYSIS Medical

HQ: United Kingdom Website
  • Description: Provider of medical imaging systems for the non-invasive, in-vivo detection of cancerous and pre-cancerous lesions, including the DYSIS Colposcope for imaging the cervix and lower genital tract with adjunctive acetowhitening display; DYSISmap to quantify acetowhitening and overlay a color-coded map to assist biopsy targeting; and DYSIS SMARTtrack for enhanced documentation with high-resolution images, video, and instant exam playback.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full DYSIS Medical company profile →
Indi Logo

Indi

HQ: United States Website
  • Description: Provider of diagnostic products leveraging emerging technologies to help physicians and patients diagnose and manage complex diseases, such as cancer, diabetes, and Alzheimer’s, through non-invasive blood tests that monitor tens to hundreds of disease markers simultaneously.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Indi company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for BioImagene

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to BioImagene

2.2 - Growth funds investing in similar companies to BioImagene

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for BioImagene

4.2 - Public trading comparable groups for BioImagene

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to BioImagene

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About BioImagene

What does BioImagene do?

BioImagene is a provider of digital pathology solutions for clinical diagnostics and drug discovery, delivering integrated hardware and software systems to acquire, view, share, manage, archive, and analyze tissue images in pathology laboratories, including IHC algorithms such as HER2, ER/PR, and p53.

Who are BioImagene's competitors?

BioImagene's competitors and similar companies include Bicara Therapeutics, Algeta, CellGate, DYSIS Medical, and Indi.

Where is BioImagene headquartered?

BioImagene is headquartered in United States.

How many employees does BioImagene have?

BioImagene has 1,000 employees 🔒.

When was BioImagene founded?

BioImagene was founded in 2010 🔒.

What sector and industry vertical is BioImagene in?

BioImagene is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for BioImagene

Who are the top strategic acquirers in BioImagene's sector and industry

Top strategic M&A buyers and acquirers in BioImagene's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for BioImagene?

Top strategic M&A buyers groups and sectors for BioImagene include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in BioImagene's sector and industry vertical

Which are the top PE firms investing in BioImagene's sector and industry vertical?

Top PE firms investing in BioImagene's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in BioImagene's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in BioImagene's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in BioImagene's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to BioImagene include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in BioImagene's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for BioImagene?

The key public trading comparables and valuation benchmarks for BioImagene include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for BioImagene for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for BioImagene with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in BioImagene's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for BioImagene with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in BioImagene's' sector and industry vertical?

Access recent funding rounds and capital raises in BioImagene's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for BioImagene